About this Journal Submit a Manuscript Table of Contents
ISRN Biochemistry
Volume 2012 (2012), Article ID 728571, 12 pages
Review Article

Calpain Dysregulation in Alzheimer’s Disease

Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, 303 E. Chicago Avenue, Ward 8-140, Chicago, IL 60611, USA

Received 26 August 2012; Accepted 12 September 2012

Academic Editors: A. Caceres and B. Lenarcic

Copyright © 2012 Adriana Ferreira. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [9 citations]

The following is the list of published articles that have cited the current article.

  • MaryKate McBrayer, and Ralph A. Nixon, “Lysosome and calcium dysregulation in Alzheimer's disease: partners in crime,” Biochemical Society Transactions, vol. 41, pp. 1495–1502, 2013. View at Publisher · View at Google Scholar
  • Kendall R. Walker, and Giuseppina Tesco, “Molecular mechanisms of cognitive dysfunction following traumatic brain injury,” Frontiers In Aging Neuroscience, vol. 5, 2013. View at Publisher · View at Google Scholar
  • Ming Chen, and Huey T. Nguyen, “Our “energy-Ca2+ signaling deficits” hypothesis and its explanatory potential for key features of Alzheimer’s disease,” Frontiers in Aging Neuroscience, vol. 6, 2014. View at Publisher · View at Google Scholar
  • Regina M. Graham, John W. Thompson, and Keith A. Webster, “BNIP3 promotes calcium and calpain-dependent cell death,” Life Sciences, vol. 142, pp. 26–35, 2015. View at Publisher · View at Google Scholar
  • Mauro Fà, Hong Zhang, Agnieszka Staniszewski, Faisal Saeed, Li W. Shen, Isaac T. Schiefer, Marton I. Siklos, Subhasish Tapadar, Vladislav A. Litosh, Jenny Libien, Pavel A. Petukhov, Andrew F. Teich, Gregory R.J. Thatcher, and Ottavio Arancio, “Novel Selective Calpain 1 Inhibitors as Potential Therapeutics in Alzheimer’s Disease,” Journal of Alzheimer's Disease, vol. 49, no. 3, pp. 707–721, 2015. View at Publisher · View at Google Scholar
  • Andrew F. Teich, Russell E. Nicholls, Daniela Puzzo, Jole Fiorito, Rosa Purgatorio, Mauro Fa’, and Ottavio Arancio, “Synaptic Therapy in Alzheimer’s Disease: A CREB-centric Approach,” Neurotherapeutics, 2015. View at Publisher · View at Google Scholar
  • Fatimah Zara Javaid, Jonathan Brenton, Li Guo, and Maria F. Cordeiro, “Visual and Ocular Manifestations of Alzheimer’s Disease and Their Use as Biomarkers for Diagnosis and Progression,” Frontiers in Neurology, vol. 7, 2016. View at Publisher · View at Google Scholar
  • Tatyana Gurlo, Safia Costes, Jonathan D. Hoang, Jacqueline F. Rivera, Alexandra E. Butler, and Peter C. Butler, “β Cell–specific increased expression of calpastatin prevents diabetes induced by islet amyloid polypeptide toxicity,” JCI Insight, vol. 1, no. 18, 2016. View at Publisher · View at Google Scholar
  • Zeinab ElHajj, Amélie Cachot, Terry Müller, Irène M. Riederer, and Beat M. Riederer, “Effects of postmortem delays on protein composition and oxidation,” Brain Research Bulletin, 2016. View at Publisher · View at Google Scholar